Exosomes in acute myeloid leukemia inhibit hematopoiesis : Current Opinion in Hematology

Secondary Logo

Journal Logo

HEMATOPOIESIS: Edited by Hal E. Broxmeyer

Exosomes in acute myeloid leukemia inhibit hematopoiesis

Boyiadzis, Michaela; Whiteside, Theresa L.b

Author Information
Current Opinion in Hematology 25(4):p 279-284, July 2018. | DOI: 10.1097/MOH.0000000000000439

Abstract

Purpose of review 

Exosomes are cell-derived, biologically active membrane-bound vesicles, and are emerging as key modulators of hematopoiesis. Recent studies have provided a clearer understanding of the mechanisms whereby blast-derived exosomes act to suppress hematopoiesis in acute myeloid leukemia (AML).

Recent findings 

Exosomes released from leukemia blasts have been shown to suppress hematopoietic progenitor cell (HPC) functions indirectly through stromal reprogramming of niche-retention factors and also as a consequence of AML exosome-directed microRNA delivery to HPC. Furthermore, exosomes secreted by AML blasts remodel the bone marrow niche into a leukemia growth-permissive microenvironment.

Summary 

Exosomes suppress hematopoiesis in AML. Strategies to block the production, secretion and reprogramming that exosomes induce may be a novel therapeutic approach in AML and other leukemias.

Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.

You can read the full text of this article if you:

Access through Ovid